Anna Franzén holds an MSc in Pharmaceutical Biosciences and a PhD in Toxicology from Uppsala University, Sweden. With over 20 years’ experience in the pharmaceutical industry and regulatory environments such as the Swedish Medical Products Agency, Anna has developed a deep expertise in risk assessment, clinical research, and regulatory strategies. She has also worked extensively in industry-academic collaborations, supporting the development of innovative healthcare solutions. Anna joined Emplicure in 2021 and leads the company’s regulatory strategy. Passionate about innovation and safety, she is dedicated to advancing novel solutions for nicotine and drug delivery
All videos (1)
Is Bioceramic the Future of Nicotine Delivery? | #GFN26ScienceLab
22 Jul 2026
Can bioceramic technology change the future of nicotine delivery - or is it just another marketing buzzword?
In this video, we take a closer look at the science behind bioceramic materials and their emerging role in modern nicotine products. We examine how these materials work, what manufacturers claim they can achieve, and whether those claims are supported by current evidence.